Erlotinib
- Product NDC
- 59923-727
- 11-digit product format
- 599230727
- Labeler code
- 59923
- Product ID
- 59923-727_b8e4409c-f659-4c6d-e053-2a95a90a2526
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erlotinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Areva Pharmaceuticals
- Application
- ANDA211960
- Marketing category
- ANDA
- Marketing start
- 2020-05-01
- Marketing end
- 0000-00-00
- Substance
- ERLOTINIB HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59923-727-30 | 59923072730 | 1 BOTTLE in 1 BOX (59923-727-30) > 30 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2020-05-01 | 0000-00-00 | No | No | Current |